Home - Products - Others - Other Targets - Adropin (34-76) (human, mouse, rat)

Adropin (34-76) (human, mouse, rat)

CAS No. 1802086-30-1

Adropin (34-76) (human, mouse, rat)( —— )

Catalog No. M36656 CAS No. 1802086-30-1

Adropin (34-76) (human, mouse, rat) is a peptide that attenuates liver fibrosis and insulin resistance independent of obesity or food intake.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 193 Get Quote
5MG 377 Get Quote
10MG 550 Get Quote
25MG 745 Get Quote
50MG 915 Get Quote
100MG 1107 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Adropin (34-76) (human, mouse, rat)
  • Note
    Research use only, not for human use.
  • Brief Description
    Adropin (34-76) (human, mouse, rat) is a peptide that attenuates liver fibrosis and insulin resistance independent of obesity or food intake.
  • Description
    Adropin (34-76) (human, mouse, rat) regulates fuel selection preferences in skeletal muscle. Adropin increases insulin-induced Akt phosphorylation and cell-surface expression of GLUT4, in diet-induced obesity (DIO) mouse.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1802086-30-1
  • Formula Weight
    4499.82
  • Molecular Formula
    C190H293N55O68S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (22.22 mM; Ultrasonic )
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bisphenol B

    Bisphenol B has a binding affinity for estrogen receptors.

  • Anthracophyllone

    Anthracophyllone is a natural product from the mushroom Anthracophyllum sp. BCC18695.

  • GS-829845

    GS-829845 is a JAK1 inhibitor, the main component of the active metabolite of Filgotinib, which is approximately 10-fold less potent and has a longer half-life than the parent.